• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARTIVA, INC CARTIVA IMPLANT; PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARTIVA, INC CARTIVA IMPLANT; PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT Back to Search Results
Model Number CAR-10-US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erosion (1750); Pain (1994)
Event Date 11/06/2020
Event Type  Injury  
Manufacturer Narrative
Neither the device nor applicable imaging films were returned to the manufacturer for evaluation, therefore, the cause of the event cannot be determined.
 
Event Description
Allegedly it was reported that the patient underwent bilateral 10-mm sci implantation, with care taken to maintain the implant 2 mm proud.Initial postoperative course was unremarkable, with the exception of a left second metatarsal shaft fracture sustained when she inadvertently stepped on a piece of wood.Radiographs from this time demonstrated joint space loss.Two year follow-up radiographs demonstrated progressive deterioration of the left hallux mtp joint with shortening of the hallux and an elevatus deformity.Bilateral conversion to fusion without incident.Evaluation of the left hallus demonstrated severe erosive wear of the implant, bone loss of the proximal phalanx, and erosion of the subchondral plate with exposure of underlying trabecular bone.The implant was well fixed and there were no signs of infection.
 
Manufacturer Narrative
H6: the product was not returned for review.Image of the explanted device for the left foot shows implant in translucent appearance and with significant material loss on the articulating surface.Exact dimensions and joint conditions are difficult to assess from the intraoperative images due to lighting and resolution limits.There was no image of the explanted device used on the right foot.
 
Event Description
Allegedly it was reported that the patient underwent bilateral 10-mm sci implantation, with care taken to maintain the implant 2 mm proud.Initial postoperative course was unremarkable, with the exception of a left second metatarsal shaft fracture sustained when she inadvertently stepped on a piece of wood.Radiographs from this time demonstrated joint space loss.Two year follow-up radiographs demonstrated progressive deterioration of the left hallux mtp joint with shortening of the hallux and an elevatus deformity.Bilateral conversion to fusion without incident.Evalution of the left hallus demonstrated severe erosive wear of the implant, bone loss of the proximal phalanx, and erosion of the subchondral plate with exposure of underlying trabecular bone.The implant was well fixed and there were no signs of infection.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTIVA IMPLANT
Type of Device
PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT
Manufacturer (Section D)
CARTIVA, INC
6120 windward parkway
suite 220
alpharetta GA 30005
MDR Report Key11008360
MDR Text Key221493790
Report Number3009351194-2020-00018
Device Sequence Number1
Product Code PNW
Combination Product (y/n)N
PMA/PMN Number
K181348
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 11/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberCAR-10-US
Device Catalogue NumberCAR-10-US
Initial Date Manufacturer Received 11/18/2020
Initial Date FDA Received12/15/2020
Supplement Dates Manufacturer Received11/18/2020
Supplement Dates FDA Received02/12/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age68 YR
-
-